Study markers that predict how sarcoidosis changes over time
Part of Blood & lymphatic, Immune system & allergy, Lungs & breathing clinical trials.
This study follows adults with sarcoidosis to see which body “risk signals” (biomarkers) can predict whether the disease will get better or worse. It may help doctors monitor sarcoidosis more closely and choose the right treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older) with a confirmed diagnosis of sarcoidosis
- Your sarcoidosis diagnosis followed accepted standards, usually including a tissue biopsy and ruling out other causes
- You can safely take part in the study procedures (you must be able to tolerate them)
- You are not pregnant and not breastfeeding
- You do not have other conditions that could change the study test results, like HIV, common variable immune problems, or autoimmune disease
- You do not have other lung scarring diseases at the same time, like hypersensitivity pneumonitis or idiopathic pulmonary fibrosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a steroid medication called compound betamethasone for people with newly diagnosed pulmonary sarcoidosis (stage I or II). It may help reduce inflammation and improve symptoms compared to standard prednisone treatment.
This trial tests if rilonacept can help people with cardiac sarcoidosis, a condition where inflammation affects the heart. You may join if you have active inflammation on a PET scan despite standard treatments.
This study looks at how the immune system works in people with sarcoidosis. It may help researchers find better ways to diagnose or treat the disease in the future.
This study follows people with sarcoidosis that may or may not be affecting the heart. It uses special scans (PET and MRI) to look for heart involvement and track how the disease changes over time.
This study checks whether a special heart scan called PET/MRI can predict how sarcoidosis may affect your heart. It may help doctors better estimate heart risk and plan follow-up based on scan findings.
This trial tests an experimental drug to see if it can help people with pulmonary sarcoidosis, which affects the lungs. The drug may work by reducing inflammation, and this study will check its safety and effectiveness.
Hear when a new Sarcoidosis, Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.